RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sorrento Therapeutics Stock

Sorrento Therapeutics ROA 2025

Sorrento Therapeutics ROA

-1.21

Ticker

SRNE

ISIN

US83587F2020

WKN

A1W8DY

In 2025, Sorrento Therapeutics's return on assets (ROA) was -1.21, a 0% increase from the 0 ROA in the previous year.

Sorrento Therapeutics Aktienanalyse

What does Sorrento Therapeutics do?

Sorrento Therapeutics is a biotechnology company based in San Diego, California. It was founded in 2006 by Dr. Henry Ji and specializes in the research and development of biopharmaceuticals, particularly in the field of oncology. Sorrento Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Sorrento Therapeutics's Return on Assets (ROA)

Sorrento Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Sorrento Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Sorrento Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Sorrento Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Sorrento Therapeutics stock

What is the Return on Assets (ROA) of Sorrento Therapeutics this year?

The Return on Assets (ROA) of Sorrento Therapeutics is -1.21 undefined this year.

What was the ROA of Sorrento Therapeutics compared to the previous year?

The ROA of Sorrento Therapeutics has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Sorrento Therapeutics?

A high ROA is advantageous for investors of Sorrento Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Sorrento Therapeutics?

A low ROA can be unfavorable for investors of Sorrento Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Sorrento Therapeutics affect the company?

An increase in ROA of Sorrento Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Sorrento Therapeutics impact the company?

A reduction in the ROA of Sorrento Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Sorrento Therapeutics?

Some factors that can influence the ROA of Sorrento Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Sorrento Therapeutics important for investors?

The ROA of Sorrento Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Sorrento Therapeutics take to improve ROA?

To improve ROA, Sorrento Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Sorrento Therapeutics pay?

Over the past 12 months, Sorrento Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sorrento Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Sorrento Therapeutics?

The current dividend yield of Sorrento Therapeutics is .

When does Sorrento Therapeutics pay dividends?

Sorrento Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sorrento Therapeutics?

Sorrento Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Sorrento Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sorrento Therapeutics located?

Sorrento Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sorrento Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sorrento Therapeutics from 10/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2025.

When did Sorrento Therapeutics pay the last dividend?

The last dividend was paid out on 10/4/2025.

What was the dividend of Sorrento Therapeutics in the year 2024?

In the year 2024, Sorrento Therapeutics distributed 0 USD as dividends.

In which currency does Sorrento Therapeutics pay out the dividend?

The dividends of Sorrento Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sorrento Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sorrento Therapeutics

Our stock analysis for Sorrento Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sorrento Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.